Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1)

Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1)

Abstract Background Few patients with pancreatic cancer may be candidates for immediate surgical resection at the initial diagnosis. Even if patients with borderline resectable pancreatic cancer (BRPC), micrometastases may occur before surgery. Therefore, neoadjuvant therapy is vital for improved su...

Full description

Bibliographic Details
Main Authors: Suizhi Gao, Xiaofei Zhu, Xiaohan Shi, Kai Cao, Yun Bian, Hui Jiang, Kaixuan Wang, Shiwei Guo, Huojun Zhang, Gang Jin
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Radiation Oncology
Subjects:
Neoadjuvant
Stereotactic body radiation therapy
Chemotherapy
S-1
Gemcitabine
Borderline resectable pancreatic cancer
Online Access:http://link.springer.com/article/10.1186/s13014-019-1254-8

Internet

http://link.springer.com/article/10.1186/s13014-019-1254-8

Similar Items